Reiko Nashida Selected Research

diethyl 2- ((3- dimethylcarbamoyl- 4- ((4'- trifluoromethylbiphenyl- 2- carbonyl)amino)phenyl)acetyloxymethyl)- 2- phenylmalonate

1/2015	Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
1/2014	Combination therapy of an intestine-specific inhibitor of microsomal triglyceride transfer protein and peroxisome proliferator-activated receptor γ agonist in diabetic rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reiko Nashida Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 01/2015 - 01/2014
2	Insulin Resistance 01/2015 - 01/2014
2	Obesity 01/2015 - 01/2014
1	Glucose Intolerance 01/2015

Drug/Important Bio-Agent (IBA)

2	diethyl 2- ((3- dimethylcarbamoyl- 4- ((4'- trifluoromethylbiphenyl- 2- carbonyl)amino)phenyl)acetyloxymethyl)- 2- phenylmalonateIBA 01/2015 - 01/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2014
1	Pioglitazone (Actos)FDA Link 01/2014

Therapy/Procedure

1	Therapeutics 01/2014
1	Glycemic Control 01/2014